Jump Financial’s Sana Biotechnology SANA Stock Holding History

Jump Financial’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-108,475	Closed	-$312K	–	2411
2026 Q1	$312K	Buy	+108,475	New	+$427K	﹤0.01%	1462
2024 Q2	–	Sell	-39,400	Closed	-$394K	–	2201
2024 Q1	$394K	Buy	+39,400	New	+$295K	0.01%	1306
2023 Q4	–	Sell	-13,322	Closed	-$51.6K	–	2185
2023 Q3	$51.6K	Buy	+13,322	New	+$71.6K	﹤0.01%	1746
2023 Q2	–	Sell	-89,700	Closed	-$293K	–	2118
2023 Q1	$293K	Buy	+89,700	New	+$358K	0.01%	1125
2022 Q2	–	Sell	-37,000	Closed	-$306K	–	1974
2022 Q1	$306K	Buy	+37,000	New	+$299K	0.01%	1060

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Jump Financial's SANA Position: Q2 2026 in Review

Jump Financial sold out of Sana Biotechnology (SANA) in Q2 2026, closing a stake of 108,475 shares — an estimated $312K sold.

Jump Financial first reported a position in SANA in Q1 2022 and held it in 5 quarters. The position peaked at $394K in Q1 2024. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

Jump Financial reported no remaining Sana Biotechnology position as of Q2 2026 after selling out during the quarter.
Jump Financial sold 108,475 Sana Biotechnology shares in Q2 2026, an estimated $312K.
Jump Financial first reported a position in Sana Biotechnology in Q1 2022 and held it in 5 quarters.
Jump Financial's Sana Biotechnology position peaked at $394K in Q1 2024.
211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.